{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:04:59Z","timestamp":1793109899323,"version":"4.5.0"},"reference-count":165,"publisher":"Annual Reviews","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annu. Rev. Pharmacol. Toxicol."],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p> In vertebrates, the glucuronidation of small lipophilic agents is catalyzed by the endoplasmic reticulum UDP-glucuronosyltransferases (UGTs). This metabolic pathway leads to the formation of water-soluble metabolites originating from normal dietary processes, cellular catabolism, or exposure to drugs and xenobiotics. This classic detoxification process, which led to the discovery nearly 50 years ago of the cosubstrate UDP-glucuronic acid ( 19 ), is now known to be carried out by 15 human UGTs. Characterization of the individual gene products using cDNA expression experiments has led to the identification of over 350 individual compounds that serve as substrates for this superfamily of proteins. This data, coupled with the introduction of sophisticated RNA detection techniques designed to elucidate patterns of gene expression of the UGT superfamily in human liver and extrahepatic tissues of the gastrointestinal tract, has aided in understanding the contribution of glucuronidation toward epithelial first-pass metabolism. In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar\u2019s and Gilbert\u2019s syndrome. The role of the UGTs in metabolism and different disease states in humans is the topic of this review. <\/jats:p>","DOI":"10.1146\/annurev.pharmtox.40.1.581","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T11:46:15Z","timestamp":1027770375000},"page":"581-616","source":"Crossref","is-referenced-by-count":1348,"title":["Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease"],"prefix":"10.1146","volume":"40","author":[{"given":"Robert H.","family":"Tukey","sequence":"first","affiliation":[{"name":"Departments of Chemistry & Biochemistry and Pharmacology, Cancer Center, University of California, San Diego, La Jolla, California, 92093;"},{"name":"Department of Gastroenterology and Hepatology, Hannover Medical School, 30625 Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[{"name":"Departments of Chemistry & Biochemistry and Pharmacology, Cancer Center, University of California, San Diego, La Jolla, California, 92093;"},{"name":"Department of Gastroenterology and Hepatology, Hannover Medical School, 30625 Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"key":"b1","unstructured":"Dutton GJ. 1980.Glucuronidation of Drugs and Other Compounds.Boca Raton, FL: CRC. 268 pp."},{"key":"b2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0021-9258(19)50724-4","volume":"267","year":"1992","journal-title":"J. Biol. Chem."},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115829"},{"key":"b4","first-page":"169","volume":"10","year":"1952","journal-title":"Pediatrics"},{"key":"b5","first-page":"306","volume":"51","year":"1995","journal-title":"Prog. Nucleic Acid Res."},{"key":"b6","first-page":"125","volume":"13","year":"1995","journal-title":"Prog. Liver Dis."},{"key":"b7","doi-asserted-by":"crossref","unstructured":"Gura T. 1999. Repairing the genomes splicing mistakes.Science285:316\u201318","DOI":"10.1126\/science.285.5426.316"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1042\/bj1610543"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1042\/bj1730749"},{"key":"b10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0021-9258(17)40661-2","volume":"252","year":"1977","journal-title":"J. Biol. Chem."},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(77)90254-4"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1042\/bj1710659"},{"key":"b13","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1016\/S0021-9258(20)71333-5","volume":"259","year":"1984","journal-title":"J. Biol. Chem."},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(85)90122-2"},{"key":"b15","doi-asserted-by":"crossref","unstructured":"Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, et al. 1997. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.Pharmacogenetics7:255\u201369","DOI":"10.1097\/00008571-199708000-00001"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90538-8"},{"key":"b17","first-page":"1234","volume":"25","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70239-8"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1124\/mol.52.2.212"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1042\/bj0530037"},{"key":"b21","first-page":"134","volume":"12","year":"1956","journal-title":"Recent Prog. Hormone Res."},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(98)00044-1"},{"key":"b23","unstructured":"Coughtrie MWH. 1992. Role of molecular biology in the structural and functional characterization of the UDP-glucuronosyltransferase. InProgress in Drug Metabolism,ed. GG Gibson, 13:35\u201372. Bristol, UK: Taylor & Francis. 13th ed."},{"key":"b24","unstructured":"Burchell B, Brierley CH, Clarke DJ. 1995. Cloning and expression of human UDP-glucuronosyltransferase genes. InAdvances in Drug Metabolism in Man,ed. GM Pacifici, GN Fracchia, pp. 608\u2013 57. Luxembourg, Netherelands: Eur. Comm."},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(91)90065-T"},{"key":"b26","doi-asserted-by":"crossref","unstructured":"Wei G, Bai X, Sarkar AK, Esko JD. 1999. Formation of HNK-1 determinants and the glycosaminoglycan tetrasaccharide linkage region by UDP-GlcUA:Galactose \u03b21,3-glucuronosyltransferases.J. Biol. Chem.274:7857\u201364","DOI":"10.1074\/jbc.274.12.7857"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.19.13017"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.24.17115"},{"key":"b29","doi-asserted-by":"crossref","unstructured":"Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, et al. 1996. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.Pharmacogenetics6:1\u201342","DOI":"10.1097\/00008571-199602000-00002"},{"key":"b30","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00183-0"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1007\/s003359900539"},{"key":"b32","doi-asserted-by":"crossref","unstructured":"Haque SJ, Peterson DD, Nebert DW, Mackenzie PI. 1991. Isolation, sequence, and developmental expression of rat UGT2B2: the gene encoding a constitutive UDP glucuronosyltransferase that metabolizes etiocholanolone and androsterone.DNA Cell Biol.10:515\u201324","DOI":"10.1089\/dna.1991.10.515"},{"key":"b33","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1016\/S0021-9258(19)38595-3","volume":"265","year":"1990","journal-title":"J. Biol. Chem."},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3400837"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)80111-5"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1847"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1021\/bi00128a015"},{"key":"b38","first-page":"475","volume":"264","year":"1993","journal-title":"J. Pharm. Exp. Ther."},{"key":"b39","first-page":"1","volume":"25","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"b40","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1016\/S0021-9258(19)39016-7","volume":"265","year":"1990","journal-title":"J. Biol. Chem."},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8908"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1021\/bi00091a015"},{"key":"b43","doi-asserted-by":"publisher","DOI":"10.1042\/bj2590617"},{"key":"b44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.37.22855"},{"key":"b45","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1994.1531"},{"key":"b46","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1997.16.1143"},{"key":"b47","doi-asserted-by":"crossref","unstructured":"Harding D, Jeremiah SJ, Povey S, Burchell B. 1990. Chromosomal mapping of a human phenol UDP-glucuronosyltransferase,GNT1.Ann. Hum. Genet.54:17\u2013 21","DOI":"10.1111\/j.1469-1809.1990.tb00356.x"},{"key":"b48","doi-asserted-by":"publisher","DOI":"10.1042\/bst025s562"},{"key":"b49","doi-asserted-by":"publisher","DOI":"10.1159\/000133513"},{"key":"b50","first-page":"649","volume":"43","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"b51","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1251"},{"key":"b52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.22.8381"},{"key":"b53","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.8843"},{"key":"b54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.15.8719"},{"key":"b55","first-page":"2979","volume":"57","year":"1997","journal-title":"Cancer Res."},{"key":"b56","doi-asserted-by":"crossref","unstructured":"Wooster R, Sutherland L, Ebner T, Clarke D, Da Cruz e Silva O, Burchell B. 1991. Cloning and stable expression of a new member of the human liver phenol\/bilirubin: UDP-glucuronosyltransferase cDNA family.Biochem. J.278:465\u201369","DOI":"10.1042\/bj2780465"},{"key":"b57","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7388"},{"key":"b58","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2660(08)60399-5"},{"key":"b59","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(93)02607-I"},{"key":"b60","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91252-X"},{"key":"b61","doi-asserted-by":"crossref","first-page":"15607","DOI":"10.1016\/S0021-9258(18)66758-4","volume":"261","year":"1986","journal-title":"J. Biol. Chem."},{"key":"b62","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0750"},{"key":"b63","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/S0021-9258(19)39785-6","volume":"265","year":"1990","journal-title":"J. Biol. Chem."},{"key":"b64","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1996.15.489"},{"key":"b65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.6.3272"},{"key":"b66","first-page":"838","volume":"26","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"b67","first-page":"745","volume":"25","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"b68","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj3380489","volume":"338","year":"1999","journal-title":"Biochem. J."},{"key":"b69","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70020-3"},{"key":"b70","first-page":"73","volume":"26","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"b71","first-page":"799","volume":"22","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"b72","first-page":"50","volume":"21","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"b73","first-page":"1101","volume":"47","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"b74","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0781"},{"key":"b75","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1999.1155"},{"key":"b76","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00061-8"},{"key":"b77","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(92)90338-J"},{"key":"b78","unstructured":"Mackenzie PI, Mojarrabi B, Meech R, Hansen A. 1996. Steriod UDP glucuronosyltransferases: characterization and regulation.J. Endocrinol.150(Suppl.):S79\u201386"},{"key":"b79","first-page":"177","volume":"39","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"b80","doi-asserted-by":"publisher","DOI":"10.1006\/toxs.1998.2494"},{"key":"b81","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1997.9949"},{"key":"b82","first-page":"356","volume":"24","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"b83","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1996.0320"},{"key":"b84","first-page":"299","volume":"23","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"b85","first-page":"507","volume":"26","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"b86","doi-asserted-by":"crossref","unstructured":"Ciotti M, Lakshmi VM, Basu N, Davis BB, Owens IS, Zenser TV. 1999. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.Carcinogenesis20:1963\u201369","DOI":"10.1093\/carcin\/20.10.1963"},{"key":"b87","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/15.8.1549"},{"key":"b88","first-page":"605","volume":"27","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"b89","first-page":"659","volume":"22","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"b90","first-page":"860","volume":"26","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"b91","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111435"},{"key":"b92","doi-asserted-by":"publisher","DOI":"10.1159\/000029129"},{"key":"b93","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)81020-6"},{"key":"b94","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90902-5"},{"key":"b95","doi-asserted-by":"crossref","unstructured":"Peters WH, Kock L, Nagengast FM, Kremers PG. 1991. Biotransformation enzymes in human intestine: critical low levels in the colon?Gut32:408\u201312","DOI":"10.1136\/gut.32.4.408"},{"key":"b96","doi-asserted-by":"publisher","DOI":"10.3109\/00498258809041723"},{"key":"b97","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90329-5"},{"key":"b98","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90234-1"},{"key":"b99","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02224-4"},{"key":"b100","first-page":"647","volume":"54","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"b101","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00534-0"},{"key":"b102","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0842"},{"key":"b103","doi-asserted-by":"publisher","DOI":"10.1042\/bj2420581"},{"key":"b104","doi-asserted-by":"publisher","DOI":"10.1021\/bi00091a015"},{"key":"b105","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03627-J"},{"key":"b106","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2760(98)00115-5"},{"key":"b107","doi-asserted-by":"crossref","unstructured":"Ciotti M, Marrone A, Potter B, Owens IS. 1997. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.Pharmacogenetics7:485\u201395","DOI":"10.1097\/00008571-199712000-00007"},{"key":"b108","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007322"},{"key":"b109","unstructured":"Bissel DM. 1986. Heme catabolism and bilirubin formation. InBile Pigments and Jaundice,ed. JD Ostrow, pp. 133\u201356. New York: Dekker"},{"key":"b110","unstructured":"Manns MP, Strassburg CP. 1996. Chronic hepatitis. InCurrent Therapy in Allergy Immunology and Rheumatology,ed. LM Lichtenstein, AS Fauci, pp. 301\u20139. Philadelphia, PA: Mosby"},{"key":"b111","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-9258(17)35280-8","volume":"266","year":"1991","journal-title":"J. Biol. Chem."},{"key":"b112","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1991.10.487"},{"key":"b113","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","year":"1994","journal-title":"J. Biol. Chem."},{"key":"b114","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199406000-00002"},{"key":"b115","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90702-5"},{"key":"b116","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90029-C"},{"key":"b117","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117604"},{"key":"b118","doi-asserted-by":"crossref","first-page":"23573","DOI":"10.1016\/S0021-9258(19)49501-X","volume":"268","year":"1993","journal-title":"J. Biol. Chem."},{"key":"b119","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.7.3284"},{"key":"b120","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00677-1"},{"key":"b121","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.7.1183"},{"key":"b122","first-page":"241","volume":"21","year":"1901","journal-title":"Sem. Med."},{"key":"b123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511023331802"},{"key":"b124","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91273-8"},{"key":"b125","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(98)00030-1"},{"key":"b126","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.6.10.1634050"},{"key":"b127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117008"},{"key":"b128","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150531"},{"key":"b129","doi-asserted-by":"crossref","unstructured":"Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, et al. 1994. Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.Hum. Genet.94:693\u201397","DOI":"10.1007\/BF00206965"},{"key":"b130","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1993.1451"},{"key":"b131","unstructured":"Moghrabi N, Clarke DJ, Burchell B, Boxer M. 1993. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.Am. J. Hum. Genet.53:722\u201329"},{"key":"b132","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2610"},{"key":"b133","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970120)68:2<173::AID-AJMG10>3.3.CO;2-F"},{"key":"b134","doi-asserted-by":"crossref","unstructured":"Jansen PL. 1996. Genetic diseases of bilirubin metabolism: the inherited unconjugated hyperbilirubinemias.J. Hepatol.25:398\u2013404","DOI":"10.1016\/S0168-8278(96)80129-2"},{"key":"b135","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5742(99)00022-8"},{"key":"b136","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/129.2.552S"},{"key":"b137","doi-asserted-by":"publisher","DOI":"10.3109\/10409239109081125"},{"key":"b138","doi-asserted-by":"crossref","unstructured":"Rambeaud JJ. 1999. Intermittent complete androgen blockade in metastatic prostate cancer.Eur. Urol.35(Suppl. 1):32\u201336","DOI":"10.1159\/000052305"},{"key":"b139","doi-asserted-by":"crossref","unstructured":"Schroder FH. 1998. Antiandrogens as monotherapy for prostate cancer.Eur. Urol.34(Suppl. 3):12\u201317","DOI":"10.1159\/000052291"},{"key":"b140","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.12.2637"},{"key":"b141","doi-asserted-by":"crossref","unstructured":"Nowell SA, Massengill JS, Williams S, Radominska-Pandya A, Tephly TR, et al. 1999. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-\u03b2]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.Carcinogenesis20:1107\u201314","DOI":"10.1093\/carcin\/20.6.1107"},{"key":"b142","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.49.1.33"},{"key":"b143","doi-asserted-by":"publisher","DOI":"10.1210\/en.139.5.2375"},{"key":"b144","first-page":"113","volume":"15","year":"1950","journal-title":"Dtsch. Ges. Verd. Soffw."},{"key":"b145","first-page":"331","volume":"15","year":"1973","journal-title":"Clin. Exp. Immunol."},{"key":"b146","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113949"},{"key":"b147","doi-asserted-by":"crossref","unstructured":"Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, et al. 1987. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type I: a second type of \u201cautoimmune\u201d hepatitis.Hepatology7:1333\u201339","DOI":"10.1002\/hep.1840070626"},{"key":"b148","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)90027-2"},{"key":"b149","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.21.8256"},{"key":"b150","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.2.551"},{"key":"b151","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114660"},{"key":"b152","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(90)90541-6"},{"key":"b153","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.5.1353"},{"key":"b154","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.9.1751"},{"key":"b155","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91966-6"},{"key":"b156","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00081.x"},{"key":"b157","doi-asserted-by":"crossref","unstructured":"Beaune PH, Lecoeur S, Bourdi M, Gauffre A, Belloc C, et al. 1996. Anti-cytochrome P450 autoantibodies in drug-induced disease.Eur. J. Haematol.57(Suppl. 60):89\u201392","DOI":"10.1111\/j.1600-0609.1996.tb01652.x"},{"key":"b158","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80151-J"},{"key":"b159","doi-asserted-by":"crossref","unstructured":"Senafi SB, Clarke DJ, Burchell B. 1994. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.Biochem. J.303:233\u201340","DOI":"10.1042\/bj3030233"},{"key":"b160","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00095-H"},{"key":"b161","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90437-2"},{"key":"b162","first-page":"638","volume":"34","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"b163","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)81266-O"},{"key":"b164","doi-asserted-by":"crossref","first-page":"18294","DOI":"10.1016\/S0021-9258(18)55268-6","volume":"266","year":"1991","journal-title":"J. Biol. Chem."},{"key":"b165","doi-asserted-by":"crossref","first-page":"24048","DOI":"10.1016\/S0021-9258(18)54390-8","volume":"266","year":"1991","journal-title":"J. Biol. Chem."}],"container-title":["Annual Review of Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/doi\/pdf\/10.1146\/annurev.pharmtox.40.1.581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T11:32:25Z","timestamp":1634383945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/doi\/10.1146\/annurev.pharmtox.40.1.581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1146\/annurev.pharmtox.40.1.581"],"URL":"https:\/\/doi.org\/10.1146\/annurev.pharmtox.40.1.581","relation":{},"ISSN":["0362-1642","1545-4304"],"issn-type":[{"value":"0362-1642","type":"print"},{"value":"1545-4304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}